Chairman of the Board of Directors
Mr. Blumensohn joined the Board of Directors of SHL as a non-executive Director at the end of 2015 and has been elected as Chairman of the Board in Feb 2016. From 2007 to 2008, Mr. Blumensohn was a VP Cardiology of McKesson Corporation (NYSE:MCK), ranked 11th on the FORTUNE 500 list, a healthcare services and information technology company. From 1995 to 2006, Mr. Blumensohn was the Chairman of the Board and CEO of Medcon Ltd., a cardiac image and information management solutions company, traded on the Tel Aviv Stock exchange and sold to McKesson Corporation. From 2008 to 2014 Mr. Blumensohn was the CEO and Chairman of the Board of Endymed Medical Ltd. (TLV:ENDY) a medical technology company that designs, develops, and commercializes energy based aesthetic treatment systems for the professional markets. He holds a B.Sc. in Mathematics & Computer Science, an MBA and an MA in Conflict Resolutions – all from the Tel-Aviv University. Nationality: Israeli.
Mr. Shalev is the co-founder of SHL, has served as a director of SHL since its inception in 1987 and was its Chief Operating Officer from 1990 to 1993. Mr. Shalev currently serves as the Vice Chairman of the board of directors of Partner Communications Company (NASDAQ, TASE: PTNR), a leading Israeli provider of telecommunications services from 2013. Mr. Shalev was the founder of Channel 2 news in Israel and from 1993 to 1995 served as its CEO. From 1996 to 1999, he was Editor in Chief of “Yediot Aharonot”, the largest daily newspaper in Israel and from 2000-2001 he was an Executive Vice President of Discount Investment Corporation Ltd. of the IDB group. Mr. Shalev has been serving as a senior advisor to the Saban Capital Group since 2004. He was a director in several large and well known Israeli firms. Mr. Shalev holds a BA degree in Political Science from the University of Tel-Aviv, Israel. Nationality: Israeli.
Dr. Ruth Ben Yakar
Dr. Ruth Ben Yakar joined the Board of Directors of SHL as an Independent (external) Director in 2014. Dr. Ben Yakar currently serves as the CEO of BioSight Ltd., a private pharmaceutical development company, active in the field of oncology, and the Chairperson of RAM Technologies Ltd., which provides management and consulting services to biotech companies. From 2012 to 2015 Dr. Ben Yakar served as a Director at the Board of Directors of IATI (Israel Advanced Technologies Industries) organization. From 2012 to 2014, Dr. Ben Yakar was the CEO of Procognia Ltd. (TASE: PRCG), active in the biopharmaceutical analytics and development field and from 2011 to 2012, she served as the CEO of Thrombotech Ltd., a phase II clinical stage Israeli biotech company, active in the fields of CNS and cardiovascular therapeutics. From 2009 to 2011, Dr. Ben Yakar was the Chief Business Officer of YEDA Research and Development Ltd., the technology transfer company of the Weizmann Institute of Science, and from 2008 to 2009 she served as Vice President at the cell therapy company Gamida Cell Ltd. Dr. Ben Yakar currently also serves as a director on the Board of Directors of Cellect Biomed Ltd. (TASE:CLBD). Dr. Ben Yakar was awarded a Ph.D. Cum Laude, in Life Sciences, from the Weizmann Institute of Science, and a B.Sc. Cum Laude in Life Sciences from the Tel-Aviv University. Nationality: Israeli.
Mr. Alroy re-joined the SHL Board of Directors as a non-executive Director in 2016. Mr. Alroy served in various executive positions in SHL Telemedicine since its inception, as its Co-CEO from 2000 to January 2015 and as a director from 2008 to 2014.He is currently active in various investments and is a board member in Merhavia Holdings Ltd (TASE:MRHL) and is the Chairman of Migvan Engineering and Technology Ltd.Mr. Alroy holds an MBA from the Hebrew University in Jerusalem. Nationality: Israeli.
Dr. Amir Lerman
Dr. Lerman joined the Board of Directors of SHL as a non-executive Director in 2016. Dr. Lerman is the Director of the Cardiovascular Research Center at the Mayo Clinic in Rochester (USA) since 2013. He is also the Program Director for vascular and valve, Center for Regenerative Medicine at the Mayo Clinic, since 2012, and Vice-Chair, Cardiovascular Department and chair for Cardiovascular research at the Mayo Clinic, since 2013. In addition, Dr. Lerman serves as the Director of the Mayo-Israeli start up company initiative as well as a faculty member at the Mirage Institute: US-Israel innovation bridge business leadership program, since 2009, in addition to various other positions held at the Mayo Clinic. Dr. Lerman also holds an appointment as Professor of Medicine at the Mayo Medical School since 2001. Dr. Lerman graduated from the Technion school of Medicine in Haifa Israel in 1985 and completed his training in internal medicine, cardiovascular diseases and invasive cardiology at the Mayo Clinic in 1994. Dr. Lerman published more than 500 manuscripts, book chapters and reviews; the NIH, AHA, and several foundations support his research. Nationality: American/ Israeli.
Mr. Harel has joined the Board of Directors of SHL as an Independent (external) Director on January 2017.
Mr. Harel is currently working on his Ph.D. in Business Administration at Ben-Gurion University, and bringing with him over two decades of versatile management and business experience.
Between 2003-2013, Mr. Harel served as a CEO of four operating companies, building and implementing new strategic plans and managing their exit strategy; CT-Ware Ltd., a leading provider of cloud based virtual call center solution, Tomcar Ltd., a global company dealing with developing, manufacturing and marketing of Off Road vehicles, Maxi Media Outdoor Advertising Ltd., the leading company in Israel for outdoor advertising and Yatzil Finances Ltd.
During 1997-2002, Mr. Harel served as Co-CEO of Poalim Communications Ltd., an investments and holding company where he had direct involvement as member of the board of directors at most of the company’s subsidiaries.
Mr. Harel is serving today as a member of the board of directors at Kerur Holdings Ltd., C. Mer Industries Ltd. and Leader Capital Markets Ltd.
Mr. Harel holds a B.A. in Economics (Cum Laude), an M.B.A. and an M.A. in Philosophy (Cum Laude) from Tel Aviv University and has completed the International Management Program at N.Y.U. School of Business Administration.